Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Andorfer

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Journal of Biotechnology|August 6, 2024
Orthogonal characterization of rAAV9 reveals unexpected transgene heterogeneityPeter Eisenhut, Peter Andorfer, Andrea Haid, et al.
Journal of Biotechnology|December 19, 2024
Potency by design: Novel insights in transfection and purification for manufacturing of rAAV gene therapy vectorsAndreas Maccani, Robert Pachlinger, Peter Eisenhut, et al.
Biotechnology Journal|September 9, 2024
Cas-CLOVER-mediated knockout of STAT1: A novel approach to engineer packaging HEK-293 cell lines used for rAAV productionPeter Andorfer, Carolin-Isabel Kahlig, Doris Pakusic, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Journal of Biotechnology|August 6, 2024
Orthogonal characterization of rAAV9 reveals unexpected transgene heterogeneityPeter Eisenhut, Peter Andorfer, Andrea Haid, et al.
Journal of Biotechnology|December 19, 2024
Potency by design: Novel insights in transfection and purification for manufacturing of rAAV gene therapy vectorsAndreas Maccani, Robert Pachlinger, Peter Eisenhut, et al.
Biotechnology Journal|September 9, 2024
Cas-CLOVER-mediated knockout of STAT1: A novel approach to engineer packaging HEK-293 cell lines used for rAAV productionPeter Andorfer, Carolin-Isabel Kahlig, Doris Pakusic, et al.
Pageof 2